Skip to main content
NCBI home page
Nucleic Acids Research logoLink to Nucleic Acids Research
. 1993 Dec 25;21(25):5909–5915. doi: 10.1093/nar/21.25.5909

Modulation of oligonucleotide duplex and triplex stability via hydrophobic interactions.

S M Gryaznov 1, D H Lloyd 1
PMCID: PMC310473  PMID: 8290352

Abstract

Synthetic oligonucleotides have been proposed as a new rationally designed class of pharmaceuticals with a mechanism of action based upon a Watson-Crick and/or Hoogsteen type of base pairing with RNA or DNA regions of interest. Two series of 3'-cholesterol and/or 5'-cholesterol conjugated oligonucleotides have been synthesized. The primary structure of these compounds was conceived in a way that should allow a hydrophobic interaction to take place upon bringing the cholesteryl moieties into proximity via a hybridization event. In the first group of compounds the cholesteryl group was tethered to the opposite ends of two oligonucleotides, tandemly addressed to the same complementary strand. An increase in the Tm of duplexes up to 13.3 degrees C was observed in comparison to unmodified oligomers. We observed a higher level of mismatch discrimination for the two contiguous oligonucleotide cholesterol conjugates compared to one continuous oligomer of the same length. A second group of compounds was synthesized as 5',3'-bis-cholesterol containing oligomers, capable of forming 'clamp-shaped' triple-stranded complexes, where cholesterol groups were attached to the termini of duplex and triplex forming domains. Stabilization of triplexes by up to 30 degrees C due to inter-cholesteryl interaction was observed. We detected no triplex formation with a mismatched target. These data suggest that significant stabilization of complexes of nucleic acids could be achieved through inter-cholesteryl hydrophobic interaction.

Full text

PDF
5909

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barone A. D., Tang J. Y., Caruthers M. H. In situ activation of bis-dialkylaminophosphines--a new method for synthesizing deoxyoligonucleotides on polymer supports. Nucleic Acids Res. 1984 May 25;12(10):4051–4061. doi: 10.1093/nar/12.10.4051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bielinska A., Shivdasani R. A., Zhang L. Q., Nabel G. J. Regulation of gene expression with double-stranded phosphorothioate oligonucleotides. Science. 1990 Nov 16;250(4983):997–1000. doi: 10.1126/science.2237444. [DOI] [PubMed] [Google Scholar]
  3. Bock L. C., Griffin L. C., Latham J. A., Vermaas E. H., Toole J. J. Selection of single-stranded DNA molecules that bind and inhibit human thrombin. Nature. 1992 Feb 6;355(6360):564–566. doi: 10.1038/355564a0. [DOI] [PubMed] [Google Scholar]
  4. Farooqui F., Sarin P. S., Sun D., Letsinger R. L. Effect of structural variations in cholesteryl-conjugated oligonucleotides on inhibitory activity toward HIV-1. Bioconjug Chem. 1991 Nov-Dec;2(6):422–426. doi: 10.1021/bc00012a007. [DOI] [PubMed] [Google Scholar]
  5. Giovannangéli C., Rougée M., Garestier T., Thuong N. T., Hélène C. Triple-helix formation by oligonucleotides containing the three bases thymine, cytosine, and guanine. Proc Natl Acad Sci U S A. 1992 Sep 15;89(18):8631–8635. doi: 10.1073/pnas.89.18.8631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gryaznov S. M., Letsinger R. L. Synthesis and properties of oligonucleotides containing aminodeoxythymidine units. Nucleic Acids Res. 1992 Jul 11;20(13):3403–3409. doi: 10.1093/nar/20.13.3403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Harel-Bellan A., Brini A. T., Ferris D. K., Robin P., Farrar W. L. In situ detection of a heat-shock regulatory element binding protein using a soluble synthetic enhancer sequence. Nucleic Acids Res. 1989 Jun 12;17(11):4077–4087. doi: 10.1093/nar/17.11.4077. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hélène C., Toulmé J. J. Specific regulation of gene expression by antisense, sense and antigene nucleic acids. Biochim Biophys Acta. 1990 Jun 21;1049(2):99–125. doi: 10.1016/0167-4781(90)90031-v. [DOI] [PubMed] [Google Scholar]
  9. Letsinger R. L., Alul R. A., Farooqui F., Gryaznov S. M., Kinstler O. Synthesis and properties of modified oligonucleotides. Nucleic Acids Symp Ser. 1991;(24):75–78. [PubMed] [Google Scholar]
  10. Letsinger R. L., Zhang G. R., Sun D. K., Ikeuchi T., Sarin P. S. Cholesteryl-conjugated oligonucleotides: synthesis, properties, and activity as inhibitors of replication of human immunodeficiency virus in cell culture. Proc Natl Acad Sci U S A. 1989 Sep;86(17):6553–6556. doi: 10.1073/pnas.86.17.6553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lokhov S. G., Podyminogin M. A., Sergeev D. S., Silnikov V. N., Kutyavin I. V., Shishkin G. V., Zarytova V. P. Synthesis and high stability of complementary complexes of N-(2-hydroxyethyl)phenazinium derivatives of oligonucleotides. Bioconjug Chem. 1992 Sep-Oct;3(5):414–419. doi: 10.1021/bc00017a010. [DOI] [PubMed] [Google Scholar]
  12. MacKellar C., Graham D., Will D. W., Burgess S., Brown T. Synthesis and physical properties of anti-HIV antisense oligonucleotides bearing terminal lipophilic groups. Nucleic Acids Res. 1992 Jul 11;20(13):3411–3417. doi: 10.1093/nar/20.13.3411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Marshall W. S., Caruthers M. H. Phosphorodithioate DNA as a potential therapeutic drug. Science. 1993 Mar 12;259(5101):1564–1570. doi: 10.1126/science.7681216. [DOI] [PubMed] [Google Scholar]
  14. Matsukura M., Shinozuka K., Zon G., Mitsuya H., Reitz M., Cohen J. S., Broder S. Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus. Proc Natl Acad Sci U S A. 1987 Nov;84(21):7706–7710. doi: 10.1073/pnas.84.21.7706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Morvan F., Porumb H., Degols G., Lefebvre I., Pompon A., Sproat B. S., Rayner B., Malvy C., Lebleu B., Imbach J. L. Comparative evaluation of seven oligonucleotide analogues as potential antisense agents. J Med Chem. 1993 Jan 22;36(2):280–287. doi: 10.1021/jm00054a013. [DOI] [PubMed] [Google Scholar]
  16. Stein C. A., Pal R., DeVico A. L., Hoke G., Mumbauer S., Kinstler O., Sarngadharan M. G., Letsinger R. L. Mode of action of 5'-linked cholesteryl phosphorothioate oligodeoxynucleotides in inhibiting syncytia formation and infection by HIV-1 and HIV-2 in vitro. Biochemistry. 1991 Mar 5;30(9):2439–2444. doi: 10.1021/bi00223a020. [DOI] [PubMed] [Google Scholar]
  17. Svinarchuk F. P., Konevetz D. A., Pliasunova O. A., Pokrovsky A. G., Vlassov V. V. Inhibition of HIV proliferation in MT-4 cells by antisense oligonucleotide conjugated to lipophilic groups. Biochimie. 1993;75(1-2):49–54. doi: 10.1016/0300-9084(93)90024-m. [DOI] [PubMed] [Google Scholar]
  18. Szczylik C., Skorski T., Nicolaides N. C., Manzella L., Malaguarnera L., Venturelli D., Gewirtz A. M., Calabretta B. Selective inhibition of leukemia cell proliferation by BCR-ABL antisense oligodeoxynucleotides. Science. 1991 Aug 2;253(5019):562–565. doi: 10.1126/science.1857987. [DOI] [PubMed] [Google Scholar]
  19. Tuerk C., Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science. 1990 Aug 3;249(4968):505–510. doi: 10.1126/science.2200121. [DOI] [PubMed] [Google Scholar]
  20. Wu H., Holcenberg J. S., Tomich J., Chen J., Jones P. A., Huang S. H., Calame K. L. Inhibition of in vitro transcription by specific double-stranded oligodeoxyribonucleotides. Gene. 1990 May 14;89(2):203–209. doi: 10.1016/0378-1119(90)90007-e. [DOI] [PubMed] [Google Scholar]
  21. Zamecnik P. C., Stephenson M. L. Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. Proc Natl Acad Sci U S A. 1978 Jan;75(1):280–284. doi: 10.1073/pnas.75.1.280. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Nucleic Acids Research are provided here courtesy of Oxford University Press

RESOURCES